Paul Sekhri

Mr. Sekhri has served as a member of our board of directors since September 2004. Since January 2009, Mr. Sekhri has served as head of TPG Biotech, a financial services institution. From December 2004 to December 2008, Mr. Sekhri served as president and chief executive officer of Cerimon Pharmaceuticals, Inc., a biopharmaceutical company. Prior to founding Cerimon, from October 2003 to December 2004, Mr. Sekhri was president and chief business officer of ARIAD Pharmaceuticals, Inc., an oncology company. From December 2002 to September 2003, Mr. Sekhri was a partner at the Sprout Group, a venture capital affiliate of Credit Suisse, a financial services institution. From August 1999 to January 2003, Mr. Sekhri held various positions with Novartis Pharma AG, a pharmaceutical company, most recently as its senior vice president and head of global search and evaluation. Mr. Sekhri received his M.Sc. and B.Sc. from the University of Maryland, School of Medicine. Mr. Sekhri also serves on the board of directors at A.P.T. Pharmaceuticals, KAI Pharmaceuticals, and the Cancer Research Institute. He is also a member of the Advisory Board for the BioExec Institute, Inc. and an advisor to the Brookings Global Health Financing Initiative.